There are 2789 resources available
26P - Structurally constrained tumor-specific epitope within the largest extracellular domain of sodium-dependent phosphate transporter NaPi2b
Presenter: Leysan Bulatova
Session: ePoster Display
27P - Oxidized low-density lipoprotein induces cell dead and inflammation in cardiomyocytes exposed to nivolumab by TLR4/NF-κB and NLRP3/myd88 pathways
Presenter: Martina Iovine
Session: ePoster Display
46P - Intraperitoneal perfusion with sodium bicarbonate solution can significantly increase the lifespan of mice with Ehrlich ascites carcinoma
Presenter: Alexey Bogdanov
Session: ePoster Display
47P - Derazantinib for patients with intrahepatic cholangiocarcinoma harboring FGFR2 fusions/rearrangements: Primary results from the phase II study FIDES-01
Presenter: Michele Droz Dit Busset
Session: ePoster Display
48P - (BREGO) Regorafenib combined with modified m-GEMOX in patients with advanced biliary tract cancer (BTC): A phase II randomized trial
Presenter: Eric Assenat
Session: ePoster Display
49P - A phase II trial of nivolumab and gemcitabine and S-1 as the first-line treatment in patients with advanced biliary tract cancer
Presenter: Nai-Jung Chiang
Session: ePoster Display
51P - Pooled analysis safety profile of futibatinib in patients with advanced solid tumors, including intrahepatic cholangiocarcinoma (iCCA)
Presenter: Funda Meric-Bernstam
Session: ePoster Display
52P - Assessment of futibatinib exposure–response (E–R) relationships in patients with advanced solid tumors, including cholangiocarcinoma (CCA)
Presenter: Antoine Hollebecque
Session: ePoster Display
30P - Targeting of BCR-ABL gene expression in K562 cells using cell-penetrating peptide nanocomplexes carrying siRNAs
Presenter: Vera Vysochinskaya
Session: ePoster Display